laitimes

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

author:呱呱668

The National Health Insurance Administration recently issued an important reminder to warn everyone to be careful of some characteristic drugs, as they may be so-called "reflux drugs". This reminder has attracted a lot of attention because it involves everyone's health and safety.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

"Reflux drugs" refer to drugs that have been reflowed back into the healthcare system, and in layman's terms, drugs that have been repackaged, labeled, or have had their manufacturing date changed. These drugs may have expired, become ineffective, or even counterfeit and substandard drugs, posing a serious threat to human health.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

In order to protect the drug safety of the general public, the National Health Insurance Administration reminds everyone to be vigilant against the following characteristic drugs:

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Medicines with damaged, dirty, or illegible packaging;

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Drugs with missing labels and confusing fonts;

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Drugs with unclear and ambiguous production date and batch number;

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Drugs that are unusually inexpensive and exaggerate their efficacy.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

If you find drugs with similar characteristics around you, you must be vigilant and do not blindly buy and use them, so as not to bring unnecessary risks to your health.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

In addition to the reminder of the National Health Insurance Administration, we should also be vigilant in our daily life, choose regular hospitals and pharmacies to buy drugs, and avoid buying drugs from unknown sources and doubtful quality.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

In addition, as a citizen, we should also actively participate in the fight against counterfeit medicines. If it is found that someone is selling counterfeit drugs or is suspected of manufacturing and selling counterfeit drugs, it is necessary to report to the relevant departments in a timely manner, and jointly maintain a good medical environment and social order.

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

While maintaining our own health, we also hope that each of us can contribute to the harmony and tranquility of society. Let's join hands to create a safe and healthy living environment!

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

If you have any questions about drug safety or health, you can leave a message in the comment area, and I will try my best to answer for you. Wishing you all health and happiness!

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Thank you for watching, you can communicate in the comment area

The National Health Insurance Administration urgently reminds: be wary of these characteristic drugs and beware of the risk of "reflux drugs"!

Read on